USE OF TRANSGENIC MUTANT MICE AS A MODEL TO STUDY THE MOLECULAR CONTROL OF BONE DEVELOPMENT AND PERIPHERAL MYELINATION AND TO DEVELOP NEW GENE THERAPY STRATEGIES IN THE EMBRYO
- 3 Anni 1995/1998
- 108.456€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- 1996 DEVELOPMENT
Defective bone formation in Krox-20 mutant mice
- 1996 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
Role of Krox-20 in endochondral bone formation
- 1998 GENE THERAPY
Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system
- 1998 MOLECULAR ENDOCRINOLOGY
Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice
- 1998 GENE THERAPY
Polyethylenimine-based intravenous delivery of transgenes to mouse lung
- 1997 JOURNAL OF NEUROSCIENCE RESEARCH
Differential regulation of the zinc finger genes Krox-20 and Krox-24 (Egr-1) suggests antagonistic roles in Schwann cells
